Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2 Postoperative Nausea and Vomiting 1 Pain, Postoperative 1 Pain 1 Intracranial Aneurysm 1 Hyperalgesia 1 Fibrosis 1 Diabetes Mellitus 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Blood Specimen Collection 4 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 navitoclax 1 maltodextrin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 Viusid 1 Vitamin E 1 Vitamin D 1 Tenofovir 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fibrosis × esmolol × Clear all

NCT05769868 2024-10-01

CIBERbBECHO

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Phase 3 Recruiting

Diabetes Mellitus, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡